Silexion Therapeutics Corp (SLXNW) Operating income 2023–2025
Silexion Therapeutics Corp (SLXNW) annual operating income history from SEC filings — each fiscal year as reported.
-$11.6MFY2025 · since FY2023: -$4.7M → -$11.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$11.6M | +7.5% |
| FY2024 | -$12.6M | -168.6% |
| FY2023 | -$4.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SLXNW financial trends
SLXNW RevenueSLXNW Net incomeSLXNW Net marginSLXNW Gross profitSLXNW Gross marginSLXNW Operating marginSLXNW Operating cash flowSLXNW Free cash flowSLXNW Capital expendituresSLXNW Return on equitySLXNW Stock buybacksSLXNW Dividends paidSLXNW Total assetsSLXNW Total liabilitiesSLXNW Shareholders’ equitySLXNW overview →